A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: Impact on seizures, severity, and quality of life

Epilepsy and Behavior

Volumn 7, Issue 3, 2005, Pages 472-480

  Kerr, Michael P ^a   Baker, Gus A ^b   Brodie, Martin J ^c  

^a Welsh Centre for Learning Disabilities   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

Epilepsy; Intellectual disability; Quality of life; Randomized controlled trial; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; PHENYTOIN; PLACEBO; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; AGGRESSION; ANOREXIA; ARTICLE; ASTHENIA; ASTHMA; BODY WEIGHT DISORDER; BRONCHITIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DIGESTIVE SYSTEM DISEASE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; FEMALE; FOCAL EPILEPSY; GAIT DISORDER; GRAND MAL SEIZURE; HEART ARRHYTHMIA; HOSTILITY; HUMAN; HYPOTENSION; INFECTION; INJURY; INTELLECTUAL IMPAIRMENT; MAINTENANCE THERAPY; MALE; MENTAL INSTABILITY; METABOLIC DISORDER; NERVOUSNESS; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; PERSONALITY DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SEIZURE; SIDE EFFECT; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; WEIGHT REDUCTION; WELLBEING;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTICONVULSANTS; BODY WEIGHT; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; INTELLIGENCE TESTS; MALE; MENTAL RETARDATION; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SEIZURES; SEX CHARACTERISTICS;

EID: 27744541145     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2005.07.006     Document Type: Article

References (29)

1. C. Bowley M. Kerr Epilepsy and intellectual disability J Intellect Disabil Res 44 2000 529-543
2. S.A. Richardson M. Katz H. Koller J. McLaren B. Rubenstine Some characteristics of a population of mentally retarded young adults in a British city J Ment Defic Res 23 1979 275-287
3. J. Corbett Epilepsy and mental handicap In: J. Laidlaw A. Richens J. Oxley editors. A textbook of epilepsy 3rd ed. 1993 Churchill Livingstone Edinburgh 631-636
4. M. Kerr W. Fraser D. Felce Primary healthcare for people with a learning disability: A keynote review Br J Learn Disabil 24 1996 2-8
5. E. Mariani L. Ferini-Strambi M. Sala C Erminio S. Smirne Epilepsy in institutionalized patients with encephalopathy: Clinical aspects and nosological considerations Am J Ment Retard 98 Suppl. 1993 27-33
6. Welsh health survey. Cardiff: Welsh Office; 1995.
7. D. Chadwick Epilepsy J Neurol Neurosurg Psychiatry 57 1994 264-277
8. M. Kerr C.A. Espie Learning disability and epilepsy: 1. Towards common outcome measures Seizure 6 1997 331-336
9. E.S. Tobias A.F. Brodie M.J. Brodie An outcome audit at the epilepsy clinic: Results from 1000 consecutive patients Seizure 3 1994 37-43
10. N. Lennox M. Taylor T. Rey-Conde C. Bain D. Purdie F. Boyle Beating the barriers: Recruitment of people with intellectual disability to participate in research J Intellect Disabil Res 49 2005 296-305
11. The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalography (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
12. T. Glauser R. Sachdeo F. Ritter R. Reife P. Lim A double-blind trial of topiramate in Lennox-Gastaut syndrome Epilepsia 38 1997 131
13. J. Motte E. Trevathan M.N. Barrera E.L. Mullens P. Manasco Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome N Engl J Med 337 1997 1807-1812
14. Sachdeo RC, Glauser, TA, Ritter F, Reife R, Lim P, Pledger G, for the Topiramate YL Study. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-7.
15. C. Chiron O. Dulac D. Beaumont L. Palacios N. Pajot J. Mumford Therapeutic trial of vigabatrin in refractory infantile spasms J Child Neurol 6 1991 S52-S59
16. R. Appleton L. Thornton for the Infantile Spasm Study Group. Double blind comparison of vigabatrin versus placebo in newly diagnosed and previously untreated infantile spasms Epilepsia 37 1996 125
17. N. Alvarez F. Besag M. Iivanainen Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability Intellect Disabil Res 42 Suppl. 1 1998 1-15
18. M.P. Kerr Topiramate: Uses in people with an intellectual disability who have epilepsy J Intellect Disabil Res 42 Suppl. 1 1998 74-79
19. M. Arvio M. Sillanpaa Topiramate in long-term treatment of epilepsy in the intellectually disabled J Intellect Disabil Res 49 2005 183-189
20. B.K. Singh S. White-Scott Role of topiramate in adults with intractable epilepsy mental retardation and developmental disabilities Seizure 11 2002 47-50
21. K. Kelly L.J. Stephen G.J. Sills M.J. Brodie Topiramate in patients with learning disability and refractory epilepsy Epilepsia 43 2002 399-402
22. K. Nihira H. Leland N. Lambert Adaptive behaviour scales 1993 American Association on Mental Retardation Austin, TX
23. C.A. Espie A. Paul M. Graham M. Sterrick J. Foley C. McGarvey The epilepsy outcome scale: The development of a measure to use with carers of people with epilepsy plus intellectual disability J Intellect Disabil Res 42 1998 90-96
24. M.G. Aman N.N. Singh A.W. Stewart C.J. Field The Aberran Behaviour Checklist: A behaviour rating scale for the assessment of treatment effects Am J Ment Defic 89 1985 485-491
25. G.A. Baker A. Jacoby D.F. Smith M.E. Dewey D.W. Chadwick Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy Epilepsia 35 1994 591-596
26. M. Sharief C. Viteri E. Ben-Menachem et al. Double-blind placebo-controlled study of topiramate in patients with refractory partial epilepsy Epilepsy Res 25 1996 217-224
27. Crawford P, Brown S, Kerr M, for the Parke Davis Clinical Trials Group. A randomised open-label study of gabapentin and lamotrigine in adults with learning disability and resistance epilepsy. Seizure 2001;10:107-15.
28. Topiramate (Topamax™) Summary of Product Characteristics. High Wycombe, UK: Janssen-Cilag Ltd.
29. J.E. Ware Jr. C.D. Sherbourne The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection Med Care 30 1992 473-483